Global Markets: AstraZeneca vaccine not recommended for adults under 55

WINNIPEG, March 30 (MarketsFarm) – The following is a glance at the news moving markets in Canada and globally.

– Canada’s National Advisory Committee on Immunization (NACI) recommended on Monday the suspension of the AstraZeneca COVID-19 vaccine for people under the age of 55 due to the risk of rare but potentially fatal blood clots. Health Canada has found no reported cases out of 300,000 doses already administered, but was aware of cases in Europe. Seven provinces have already prohibited the vaccine’s use to those under the age of 55. Earlier this month, NACI recommended the shot should not be given to people 65 years of age or over, but the decision was reversed after receiving more scientific data. Today, 1.5 million doses of the vaccine are expected to enter Canada from the United States.

– Global agencies and more than 20 world leaders signed a commentary from the World Health Organization (WHO) released on Tuesday calling for an international treaty for pandemic preparedness. “We are convinced that it is our responsibility, as leaders of nations and international institutions, to ensure that the world learns the lessons of the COVID-19 pandemic,” the authors wrote. However, the heads of government for Canada, the U.S., China and Russia were not signatories.

– Reuters is reporting that major auto makers, parts companies and the United Auto Workers union is asking U.S. President Joe Biden to implement tax credits and financial incentives as part of a comprehensive plan for electric vehicles. The requests were made in a six-page letter dated March 29. Later today, Biden is expected to announce an infrastructure proposal worth at least US$3 trillion which could include support for electric vehicles.

About the author

Glacier FarmMedia Feed

GFM Network News

Glacier FarmMedia, a division of Glacier Media, is Canada's largest publisher of agricultural news in print and online.

GFM Network News's recent articles

Comments

explore

Stories from our other publications